Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy
Clinical trial NCT00646178 · COMPLETED
Trial details
- NCT number
- NCT00646178
- Sponsor
- Abbott
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Primary completion
- 2004-03-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.